Jihane Boustani

Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design

Alberto Bossi, Stéphanie Foulon, Xavier Maldonado et al. · The Lancet · 2024 · 65 citations

Factorial Design, Urology, Radiation Medicine +9

Prostate irradiation in men with de novo, low-volume, metastatic, castration-sensitive prostate cancer (mCSPC): Results of PEACE-1, a phase 3 randomized trial with a 2x2 design.

Alberto Bossi, Stéphanie Foulon, Xavier Maldonado et al. · Journal of Clinical Oncology · 2023 · 54 citations

Urology, Radiation Medicine, Pre-clinical Pharmacology +15

Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease

M. Bolla, Anouk Neven, P. Maingon et al. · Journal of Clinical Oncology · 2021 · 46 citations · Full text

Exclusive Chemoradiotherapy With or Without Radiation Dose Escalation in Esophageal Cancer: Multicenter Phase 2/3 Randomized Trial CONCORDE (PRODIGE-26)

G. Créhange, Che Mabubu M’vondo, Aurélie Bertaut et al. · International Journal of Radiation Oncology*Biology*Physics · 2021 · 43 citations

Exclusive Chemoradiotherapy, Radiation Medicine, Esophagus +9

Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators

Jihane Boustani, Aurélie Bertaut, Matthew D. Galsky et al. · Acta Oncologica · 2017 · 30 citations · Full text